États-Unis · Plateformes & données · The Motley Fool

JPMorgan Predicted Strong Wegovy Pill Sales (and Was Right). Is Novo Nordisk Stock a Buy Now?

Publié par The Motley Fool · États-Unis il y a 40 min

JPMorgan Predicted Strong Wegovy Pill Sales (and Was Right). Is Novo Nordisk Stock a Buy Now? — JPMorgan Predicted Strong Wegovy Pill Sales (and Was Right). Is Novo Nordisk Stock a Buy Now? · The Motley Fool

Résumé détaillé

Novo Nordisk lived up to expectations for its Wegovy pill in the third quarter, but it still has more work ahead.

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

À lire aussi

Apollo Global Management Sees Private Credit Demand Holding Up Despite Negative Headlines

Nvidia’s stock drops as the board reportedly prepares to remove CEO Jensen Huang

Miami International Holdings EVP sells $819,188 in stock

AEVEX shares jump as drone maker tops revenue estimates, raises outlook

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

Can PYPL Stock Build On Its Recovery? This Analyst Raises Target To $60, Burry Is Also Adding Shares